drugset / Trial / NCT01551615
A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib
NaSingle-groupOpen-labelBasic science
Summary
Study in Healthy Volunteers to Assess the Pharmacokinetics of Metformin Administered Alone and In Combination with Vandetanib
Timeline
- Start
- 2012-03
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | Oral |
| Subject | Vandetanib | Small molecule | 800 mg | Oral |
Indications
No indication recorded.